April Beach
Family · Richmond, VANPI 1679254833
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 21 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Bayer at 24.7% of the total. 2025 is the largest year on record at $229, more than ten times the $19 reported in 2023. That places this record below the midpoint for family clinicians in VA, where the typical reported total is $337.
Across 21 payments — averaging $17.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$92
- Xeris Pharmaceuticals, Inc.$70
- Novo Nordisk$63
- Dexcom, Inc.$60
- Exact Sciences$48
- Philips North America LLC$21
- plus $19 from 1 others
What the payments were for
- Food & beverage$374100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 6 | $92 |
| Xeris Pharmaceuticals, Inc. | 4 | $70 |
| Novo Nordisk | 3 | $63 |
| Dexcom, Inc. | 3 | $60 |
| Exact Sciences | 3 | $48 |
| Philips North America LLC | 1 | $21 |
| Edwards Lifesciences | 1 | $19 |
How this compares
$374 in reported general payments places this provider in the 50th percentile of 4,332 family providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 11 | $394 |
| Rosuvastatin Calcium | 15 | $138 |
| Atorvastatin Calcium | 21 | $135 |
| Levothyroxine Sodium | 20 | $101 |
| Omeprazole | 14 | $94 |
| Amlodipine Besylate | 26 | $80 |
| Pantoprazole Sodium | 11 | $60 |
| Metformin Hcl | 17 | $53 |
| Hydrochlorothiazide | 20 | $17 |
Paid to pharmacies, not to this prescriber.
Other family in Richmond
- Hochong Smith GillesRichmond$131K
- Kasiah BanksRichmond$29K
- Johanna ChristensenRichmond$24K
- Megan ZoltyRichmond$11K
- Andrea CottonVirginia Beach$696K
- Susan MooreWytheville$438K
- Ellen WermterCharlottesville$251K
- Dana StallingsFranklin$225K
- Jocelyn BrackettHerndon$199K
- Sean OlaughlinMidlothian$110K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.